Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients.
Włodarczyk
Z
Z
Department of Surgery and Renal Transplantation Unit, Poznan District Hospital, Poznan, Poland.
Oko
A
A
Glyda
M
M
Karczewski
M
M
Idasiak-Piechocka
I
I
Czekalski
S
S
D000328:Adult; D015415:Biomarkers / Q000097:blood / Q000652:urine; D002102:Cadaver; D016232:Endothelins / Q000652:urine; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D013929:Thromboxane B2 / Q000097:blood / Q000652:urine; D014019:Tissue Donors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D014665:Vasodilator Agents / Q000627:therapeutic use*
D015415:Biomarkers; D016232:Endothelins; D010919:Placebos; D014409:Tumor Necrosis Factor-alpha; D014665:Vasodilator Agents; D013929:Thromboxane B2; D010431:Pentoxifylline